2009
DOI: 10.1016/j.apradiso.2009.03.008
|View full text |Cite
|
Sign up to set email alerts
|

Skin dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
23
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(26 citation statements)
references
References 23 publications
3
23
0
Order By: Relevance
“…3,4,11 HT dose calculation inaccuracy at the air=tis-sue interface may originate from the assumed shape of the dose kernel near the surface in the TPS dose algorithms. 11,12 The measured doses by all dosimeters were within 12 6 8% difference of each other.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…3,4,11 HT dose calculation inaccuracy at the air=tis-sue interface may originate from the assumed shape of the dose kernel near the surface in the TPS dose algorithms. 11,12 The measured doses by all dosimeters were within 12 6 8% difference of each other.…”
Section: Resultsmentioning
confidence: 99%
“…Ramsey et al reported increased dose to a patients' skin, 2 while Roland et al and Kinhikar et al concluded that HT TPS overestimated the dose to the surface. 3,4 On the other hand, Hardcastle et al argued that by using a fine calculation grid, because of the tangential nature of the treatment beams used in his work on total scalp treatment, TPS was able to predict the correct dose distribution within the planning target volume (PTV) and all organs at risks (OAR) including skin. 5 This work compares surface dose measurements in phantom using optically stimulated luminescence (OSL) dosimeters, radiochromic films, Si diode QED dosimeters, and metal oxide semiconductor field-effect transistors (MOS-FET) in the case of the planning target volume close to the surface in the HT plan.…”
Section: Introductionmentioning
confidence: 98%
“…24 Further complicating matters is that the TomoTherapy planning software itself may overestimate skin dose by anywhere between 3% and 13%. [25][26][27][28] Despite these limitations, adequate breast surface dose has been shown to be achievable utilizing TomoTherapy in clinical practice both at our institution, 29 as well as others. 30,31 Special care must be taken when treating patients with breast cancer having IMRT.…”
Section: Discussionmentioning
confidence: 95%
“…The main reason was the better availability of, and longer experience with TLDs in our institution. Prior studies have not shown significant differences between both methods of dose measurements [5456]. …”
Section: Discussionmentioning
confidence: 99%